Showing 41 - 60 results of 35,931 for search '(( a greater increase ) OR ((( ((i larvae) OR (a large)) decrease ) OR ( b large decrease ))))', query time: 1.89s Refine Results
  1. 41
  2. 42

    The number of expected vaccinations decreases with the expected vaccination time, whereas the peak of infections increases. by Simon K. Schnyder (16632244)

    Published 2023
    “…B) We show 〈<i>s</i>(<i>t</i><sub><i>v</i></sub>)〉 as a function of 〈<i>t</i><sub><i>v</i></sub>〉 again, but as a heat map for a greater range of probability distributions <i>p</i><sub><i>n</i></sub>. …”
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47
  8. 48
  9. 49

    <b>Warming alters plankton body-size distributions in a large field experiment</b> by Dania Albini (20288463)

    Published 2024
    “…We found a nonlinear decrease in the overall mean body size of zooplankton with warming, with a 57% reduction at +8°C. …”
  10. 50
  11. 51
  12. 52
  13. 53
  14. 54
  15. 55
  16. 56
  17. 57

    Table4_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
  18. 58

    Table3_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
  19. 59

    Table6_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
  20. 60

    Table1_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.DOCX by Cong Xu (203537)

    Published 2022
    “…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”